WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
1. (WO1998037217) A SOLUBLE VACCINIA VIRUS PROTEIN THAT BINDS CHEMOKINES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/037217    International Application No.:    PCT/GB1998/000569
Publication Date: 27.08.1998 International Filing Date: 23.02.1998
Chapter 2 Demand Filed:    15.09.1998    
IPC:
A61K 38/16 (2006.01), C07K 14/065 (2006.01), C07K 14/07 (2006.01), C12N 15/863 (2006.01), A61K 38/00 (2006.01)
Applicants: ISIS INNOVATION LIMITED [GB/GB]; 2 South Parks Road, Oxford OX1 3UB (GB) (For All Designated States Except US).
SMITH, Geoffrey [GB/GB]; (GB) (For US Only).
NG, Aylwin [SG/GB]; (GB) (For US Only)
Inventors: SMITH, Geoffrey; (GB).
NG, Aylwin; (GB)
Agent: PRIVETT, Kathryn, L.; Stevens, Hewlett & Perkins, 1 Serjeants' Inn, Fleet Street, London EC4Y 1LL (GB)
Priority Data:
9703592.7 21.02.1997 GB
9800113.4 05.01.1998 GB
Title (EN) A SOLUBLE VACCINIA VIRUS PROTEIN THAT BINDS CHEMOKINES
(FR) PROTEINE SOLUBLE DU VIRUS DE LA VACCINE LIANT DES CHEMOKINES
Abstract: front page image
(EN)Uses for a novel chemokine-binding protein designated A41L, and chemokine-binding fragments thereof, for the treatment of conditions such as inflammation. The A41L protein binds to chemokines in the CXC group.
(FR)L'invention concerne des utilisations d'une nouvelle protéine liant des chémokines, appelée A41L, et ses fragments liant des chémokines, dans le traitement d'états tels que l'inflammation. La protéine A41L se fixe à des chémokines dans le groupe CXC.
Designated States: AU, CA, JP, US.
European Patent Office (EPO) (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)